Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Ways To Trade The Oracle Earnings

Published 12/14/2017, 01:39 PM
Updated 05/14/2017, 06:45 AM

You can see the earnings report dates in the Oracle (NYSE:ORCL) chart below. They're the big gaps on tremendous relative volume. Following these gaps, the stock has tended to run in a consolidation range until the next report. Ahead of Thursday night's report, the stock has held true to this pattern, moving in about a $2.50 range as the 200-day SMA rises up to meet it.

Momentum is building with the RSI up at 60 and the MACD crossed up and rising. And in the short term, the price has built a small symmetrical triangle into earnings. There is support lower at 49.40 and 48 then a gap to 46.40 and 44.40. There is resistance above at 51.25 and 52.80. The reaction to the last 6 earnings reports has been a move of about 5.72% on average or $2.90, making for an expected range of 47.90 to 53.20.

The at-the money December Straddles suggest a smaller $2.50 move by Expiry, with Implied Volatility at 108% above the January, at 25%. Short interest is low at 1.0%. Open interest is biggest at the 47 and 50 strikes on the Put side. On the Call side it is much bigger at 53 and 55 with some size as well at 50 and 51.
Oracle Corporation

Four Ways To Trade Oracle

  • Trade Idea 1: Buy the December 50/48.5 1×2 Put Spread for 7 cents.
  • Trade Idea 2: Buy the December 51/53 Call Spread ($0.65) and sell the December 48.5 Put for 10 cents.
  • Trade Idea 3: Buy the December/January 55 Call Calendar ($0.15) and sell the December 47 Put for a 10 cent credit.
  • Trade Idea 4: Sell the December 47/53 Strangle for a $0.55 credit.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

#1 gives the downside, with leverage and a possible entry at 48.50. #2 and #3 give the upside, using leverage and may put you in the stock at 48.5 (#2) or 47 (#3). #4 is profitable on a close from 46.45 to 53.55 at Expiry. I prefer #1 or #3, but #4 for a 1% return on the stock overnight is not bad.

I hold January 52.50 calls from earlier this fall.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.